Pär Myrelid
Pär Myrelid is an expert in Gastroenterology at Linköping University (Sweden). As of October 2026, ScienceLeadR ranks Pär Myrelid in the top 1% of experts worldwide for Inflammatory Bowel Diseases, Gastroenteritis and Colonic Diseases. Pär Myrelid has authored 187 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 557 (community average: 125). How the SLR is computed.
LeadR Profile
Gastroenterology
Subspecialties: Pharmacy - Public Health - Hepatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 187
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Vedolizumab vs TNF Antagonists and Long-Term Outcomes in Ulcerative Colitis. PMID 42789265 — colitis, hospitalization, incidence, adrenal cortex hormones, cohort studies, tumor necrosis factor inhibitors, adalimumab, therapeutics, colitis, ulcerative, colectomy, infliximab | JAMA Netw Open | 2026 | 0 |
| Declining rates of surgery in pediatric-onset inflammatory bowel disease: a Swedish nationwide register-based cohort study 2002-2022. PMID 42742266 — incidence, cohort studies, inflammatory bowel diseases, therapeutics, child | J Crohns Colitis | 2026 | 0 |
| IOIBD: the International Organization for the Study of Inflammatory Bowel Disease. PMID 42553409 — inflammatory bowel diseases, research, education | Ther Adv Gastroenterol | 2026 | 0 |
| ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. PMID 42413123 — colitis, inflammatory bowel diseases, therapeutics, colitis, ulcerative, small molecules | J Crohns Colitis | 2026 | 0 |
| ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. PMID 42381162 — colitis, appendectomy, inflammatory bowel diseases, therapeutics, colitis, ulcerative | J Crohns Colitis | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 12
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| ASAPP Study Topical 5 ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery NCT07773948 — pouchitis, colitis, proctocolectomy, restorative, therapeutics, colitis, ulcerative | Phase 4 | Not yet recruiting | 2027 |
LeadR Networks
Main global connection map